JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

As flu activity continues to rise, FirstHealth is reinforcing visitor guidelines and encouraging preventive measures to protect patients, visitors and care teams. Visitor restrictions are in place at all FirstHealth facilities.

Main Navigation

Find a Provider

Use the provider search to find providers throughout our health care network.

View All Providers

Popular Specialty Searches

Search for a Doctor

Advanced Search Options View FirstHealth Physician Group Providers Only

Medical Care

We provide expertise in all major medical and surgical specialties and numerous sub-specialties.

View All Services

Popular Searches

Search our A to Z List of Medical Services

Hospitals & Locations

Use the location search to find locations throughout our health care network.

View All Locations

Hospitals

Location Types

Search for a Location

Patients & Visitors

Learn More

Volunteer at FirstHealth

Patients & Family Services

Visitor Information

Wellness & Fitness

Explore classes and events designed to improve your health and wellbeing.

Learn More

FirstHealth News

Popular Searches

Health Classes & Events

View All Classes & Events

Fitness Classes

View All Fitness Classes

Site Search

Search for providers, medical specialties or locations.

FirstHealth News

How can we help you?

Sub Heading

Clinical Trials Details

Back to Results

Addition of Atezolizumab (Immunotherapy) to Standard Chemotherapy

IRB Protocol Number

S2012

Clinical Trial Categories

Solid Tumors

Contact

Clinical Trials at 910-715-2200

How to Participate

Eligibility: Men and Women, 18 years or older with non-lung, metastatic small cell neuroendocrine cancer

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.